Atara Biotherapeutics Enters Strategic Manufacturing Partnership with Fujifilm

Fujifilm to Acquire Atara’s Cell Therapy Manufacturing Facility for Total Upfront Financial Consideration of USD 100 Million Parties to Enter Long-Term Supply Agreement for Clinical and Commercial Product Manufacturing Transaction Expected to Result in Reduced Operating Expenses for Atara Upon Closing, Atara’s Cash Expected to Fund Planned Operations into Q4 2023 Company to Host Live…

Read More